Direct to Patient: How Pharma is Rewriting the Marketing Channel

We know that direct-to-consumer (DTC) distribution remains popular. The 18^th edition of Essentials of Marketing expanded coverage of the topic, and the forthcoming 2026 release will provide updates. For a recent look at this see “4 Big Trends For DTC E-Commerce Growth In 2025,” (Forbes, April 17, 2025).

A recent article in The Wall Street Journal (December 8, 2025), describes how “Drugmakers Are Pitching Middlemen to Sell Directly to Patients.” Pharmaceutical companies are embracing a new marketing model: selling drugs directly to patients via their own online platforms. This trend, particularly visible in the weight-loss drug market with blockbuster products like Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy, is reshaping traditional marketing channels. Instead of going through pharmacy-benefit managers (PBMs) and wholesalers, these firms are building direct-to-consumer (DTC) websites where patients can consult doctors (often via telehealth), receive prescriptions, and get drugs shipped—often at discounted prices.

This shift is about more than just cost savings—it’s about taking control of the customer journey. Drugmakers are providing personalized digital experiences that reflect how consumers increasingly expect to interact with the healthcare system. By removing traditional middlemen and integrating services such as physician referrals, transparent pricing, and home delivery, pharmaceutical companies are adopting strategies from e-commerce and digital-first brands. However, they still face challenges in product categories where insurance coverage is strong or where drug administration requires professional supervision.

A first draft of this blog post and the image above was generated by ChatGPT.

Relevant Chapters in Essentials of Marketing

This article provides an example and a possible discussion opportunity for Chapters 10, 12, and 13. Chapter 10 directly discusses benefits of DTC and channel intermediaries, while Chapter 12 examines retailers and wholesalers. A more advanced issue an instructor might consider is how Promotion changes when going DTC.

Class Discussion Ideas

In-Class Activities

The following activities could be done in a think-pair-share exercise.

Channel Map Creation: Have students draw and compare a traditional pharma distribution channel with the direct-to-consumer model shown in the article. An instructor might show Exhibit 12-2 to demonstrate how a channel map might look.

Customer Journey Mapping: Ask students to outline the “patient journey” from awareness to purchase using LillyDirect or a similar DTC service. There is a graphic example of a customer journey map in Chapter 7.

Discussion Questions (and Answer Ideas)

If this article is assigned to students, an instructor might use the questions below to foster class discussion.

1. What benefits do pharmaceutical companies gain by going direct-to-patient? (Chapter 10)
   • Answer: More control over customer experience, data collection, brand loyalty, higher margins if volume offsets lower prices.
2. How does this shift affect traditional channel partners like PBMs? (Chapter 10)
   • Answer: They lose negotiating power and revenue from rebates; may respond by lobbying or adjusting pricing strategies.
3. Why is the weight-loss drug market particularly suited for this strategy? (Chapter 5)
   • Answer: Low insurance coverage, high consumer demand, social media visibility, and a motivated target segment.
4. How does direct-to-consumer selling improve customer service in this context? (Chapters 13 and 14)
   • Answer: Streamlined access, easier scheduling with doctors, transparency in pricing, convenience of home delivery.
5. What risks do drugmakers face with this strategy? (Chapter 10)
   • Answer: Lower price points could reduce margins if scale isn’t achieved, potential backlash from PBMs or regulators.
6. How might social media influence demand for products like Zepbound and Wegovy? (Chapters 13 and 16).
   • Answer: Peer influence, before-and-after photos, celebrity endorsements all act as earned media generating organic demand.
7. How is the patient “experience” similar to e-commerce models?j (Chapters 13, 14 and 16)
   • Answer: Personalized website interfaces, integrated checkout, virtual appointments, follow-up marketing emails.
8. What other industries have succeeded by bypassing traditional distribution channels? (Chapter 10)
   • Answer: Dell (PCs), Warby Parker (eyewear), Tesla (cars) — all use direct models for cost savings and consumer relationships.